AR038029A1 - Derivados de benzotiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen - Google Patents
Derivados de benzotiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienenInfo
- Publication number
- AR038029A1 AR038029A1 ARP020104933A ARP020104933A AR038029A1 AR 038029 A1 AR038029 A1 AR 038029A1 AR P020104933 A ARP020104933 A AR P020104933A AR P020104933 A ARP020104933 A AR P020104933A AR 038029 A1 AR038029 A1 AR 038029A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- branched
- linear
- aryl
- benzotiazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/02—1,2-Thiazines; Hydrogenated 1,2-thiazines
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Compuestos de fórmula (1) en la cual: R1 representa un grupo hidroxi, RCO-O-; R2 representa H, halógeno, un grupo hidroxi o un grupo R´CO-O; R, R´, idénticos o diferentes representan un grupo alquilo C1-6 lineal o ramificado, eventualmente substituido por un grupo arilo, un grupo alquenilo C2-6 lineal o ramificado eventualmente substituido por un grupo arilo, perhalógenoalquilo C1-6 lineal o ramificado, cicloalquilo C3-7, adamantilo, arilo o heteroarilo; R3 representa H o un grupo alquilo C1-6 lineal o ramificado, o un grupo cicloalquilo C3-7, A representa un grupo CR4R5, o un grupo NR4, R4 representa H o un grupo alquilo C1-6 lineal o ramificado, sus isómeros, así como sus sales de adición con un ácido o con una base farmacéuticamente aceptable: Son moduladores de receptores AMPA. Medicamentos para tratar desórdenes en la memoria y aprendizaje asociado con la edad, síndrome de ansiedad o depresión, enfermedades neurodegenerativas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0116622A FR2833950B1 (fr) | 2001-12-21 | 2001-12-21 | Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038029A1 true AR038029A1 (es) | 2004-12-22 |
Family
ID=8870810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020104933A AR038029A1 (es) | 2001-12-21 | 2002-12-18 | Derivados de benzotiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen |
Country Status (26)
Country | Link |
---|---|
US (1) | US7250411B2 (es) |
EP (1) | EP1456189B1 (es) |
JP (1) | JP2005517668A (es) |
KR (1) | KR100606606B1 (es) |
CN (1) | CN1606550A (es) |
AR (1) | AR038029A1 (es) |
AT (1) | ATE366245T1 (es) |
AU (1) | AU2002365017B2 (es) |
BR (1) | BR0215145A (es) |
CA (1) | CA2471057A1 (es) |
DE (1) | DE60221041T2 (es) |
DK (1) | DK1456189T3 (es) |
EA (1) | EA007271B1 (es) |
ES (1) | ES2289182T3 (es) |
FR (1) | FR2833950B1 (es) |
GE (1) | GEP20063758B (es) |
HU (1) | HUP0402584A2 (es) |
MA (1) | MA27089A1 (es) |
MX (1) | MXPA04005838A (es) |
NO (1) | NO20042684L (es) |
NZ (1) | NZ533330A (es) |
PL (1) | PL369767A1 (es) |
PT (1) | PT1456189E (es) |
UA (1) | UA78743C2 (es) |
WO (1) | WO2003053947A1 (es) |
ZA (1) | ZA200404296B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2856064B1 (fr) * | 2003-06-13 | 2005-08-19 | Servier Lab | Nouveaux derives de benzothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2856065B1 (fr) * | 2003-06-13 | 2005-08-19 | Servier Lab | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2865474B1 (fr) * | 2004-01-26 | 2008-06-13 | Servier Lab | Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2877338B1 (fr) * | 2004-11-03 | 2007-01-26 | Servier Lab | Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2877342B1 (fr) * | 2004-11-03 | 2007-01-26 | Servier Lab | Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2879201B1 (fr) * | 2004-12-10 | 2007-02-16 | Servier Lab | Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB0724625D0 (en) * | 2007-12-18 | 2008-01-30 | Glaxo Group Ltd | Novel compounds |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2130096A1 (fr) * | 1992-04-15 | 1993-10-28 | Jean-Claude Aloup | Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant |
AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
RU2214405C2 (ru) * | 1998-02-18 | 2003-10-20 | НьюроСёрч А/С | Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов |
FR2801587B1 (fr) * | 1999-11-30 | 2002-01-11 | Adir | Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-12-21 FR FR0116622A patent/FR2833950B1/fr not_active Expired - Fee Related
-
2002
- 2002-12-18 AR ARP020104933A patent/AR038029A1/es unknown
- 2002-12-20 UA UA20040706010A patent/UA78743C2/uk unknown
- 2002-12-20 MX MXPA04005838A patent/MXPA04005838A/es active IP Right Grant
- 2002-12-20 GE GE5644A patent/GEP20063758B/en unknown
- 2002-12-20 US US10/499,082 patent/US7250411B2/en not_active Expired - Fee Related
- 2002-12-20 NZ NZ533330A patent/NZ533330A/en unknown
- 2002-12-20 KR KR1020047009303A patent/KR100606606B1/ko not_active IP Right Cessation
- 2002-12-20 PL PL02369767A patent/PL369767A1/xx not_active Application Discontinuation
- 2002-12-20 WO PCT/FR2002/004484 patent/WO2003053947A1/fr active IP Right Grant
- 2002-12-20 EA EA200400756A patent/EA007271B1/ru not_active IP Right Cessation
- 2002-12-20 EP EP02805407A patent/EP1456189B1/fr not_active Expired - Lifetime
- 2002-12-20 CA CA002471057A patent/CA2471057A1/fr not_active Abandoned
- 2002-12-20 BR BR0215145-6A patent/BR0215145A/pt not_active IP Right Cessation
- 2002-12-20 JP JP2003554663A patent/JP2005517668A/ja active Pending
- 2002-12-20 AT AT02805407T patent/ATE366245T1/de not_active IP Right Cessation
- 2002-12-20 PT PT02805407T patent/PT1456189E/pt unknown
- 2002-12-20 ES ES02805407T patent/ES2289182T3/es not_active Expired - Lifetime
- 2002-12-20 HU HU0402584A patent/HUP0402584A2/hu unknown
- 2002-12-20 CN CNA028258142A patent/CN1606550A/zh active Pending
- 2002-12-20 DE DE60221041T patent/DE60221041T2/de not_active Expired - Fee Related
- 2002-12-20 AU AU2002365017A patent/AU2002365017B2/en not_active Ceased
- 2002-12-20 DK DK02805407T patent/DK1456189T3/da active
-
2004
- 2004-06-01 ZA ZA200404296A patent/ZA200404296B/en unknown
- 2004-06-04 MA MA27718A patent/MA27089A1/fr unknown
- 2004-06-25 NO NO20042684A patent/NO20042684L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ533330A (en) | 2006-05-26 |
EP1456189B1 (fr) | 2007-07-04 |
MXPA04005838A (es) | 2004-09-10 |
JP2005517668A (ja) | 2005-06-16 |
EA007271B1 (ru) | 2006-08-25 |
ATE366245T1 (de) | 2007-07-15 |
ES2289182T3 (es) | 2008-02-01 |
HUP0402584A2 (hu) | 2005-04-28 |
EP1456189A1 (fr) | 2004-09-15 |
BR0215145A (pt) | 2004-10-19 |
EA200400756A1 (ru) | 2004-10-28 |
GEP20063758B (en) | 2006-02-27 |
AU2002365017A1 (en) | 2003-07-09 |
US7250411B2 (en) | 2007-07-31 |
DE60221041T2 (de) | 2008-04-10 |
WO2003053947A1 (fr) | 2003-07-03 |
DK1456189T3 (da) | 2007-11-05 |
AU2002365017B2 (en) | 2007-12-13 |
CN1606550A (zh) | 2005-04-13 |
KR100606606B1 (ko) | 2006-08-01 |
CA2471057A1 (fr) | 2003-07-03 |
ZA200404296B (en) | 2005-06-01 |
PL369767A1 (en) | 2005-05-02 |
KR20040065276A (ko) | 2004-07-21 |
NO20042684L (no) | 2004-06-25 |
DE60221041D1 (de) | 2007-08-16 |
UA78743C2 (en) | 2007-04-25 |
MA27089A1 (fr) | 2004-12-20 |
PT1456189E (pt) | 2007-09-20 |
FR2833950B1 (fr) | 2005-12-16 |
US20050014744A1 (en) | 2005-01-20 |
FR2833950A1 (fr) | 2003-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2190396T3 (es) | Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
UY27092A1 (es) | Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen | |
SV2004001690A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos | |
BRPI0412527A (pt) | composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto. | |
AR089774A1 (es) | Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR051771A1 (es) | Acidos amino carboxilicos sustituidos | |
UY27427A1 (es) | Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos | |
ES2187300B1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
CU23105A3 (es) | DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS | |
BR0315296A (pt) | Derivados do ciclohexanol espirocìclicos | |
UY28859A1 (es) | Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento | |
AR005458A1 (es) | 2-oxo-y 2-tio-1,2-dihidroquinolinil-oxazolidinonas, procedimiento para su produccion, el uso de las mismas para la produccion de un medicamento ymedicamentos que los contienen | |
NO20043612L (no) | Nye fluorenkarboksylsyre-estere, fremgangsmate for fremstilling derav og anvendelse derav som legemidler | |
UY27370A1 (es) | Derivados de benzamida tiazol y composiciones farmacéuticas para inhibir la proliferación de células y métodos para su utilización | |
UY26505A1 (es) | Derivados de piperazina sustituídos, su preparación y su empleo como medicamentos | |
BRPI0408591A (pt) | derivados de 6,7,8,9-tetrahidropirimido[1,2-a] pirimidin-4-ona 8-substituìda | |
AR053082A1 (es) | DERIVADOS 8-PERFLUOROALQUIL-6,7,8,9-TETRAHIDROPIRIMIDO[1,2-A]PIRIMIDIN-4-ONA SUBSTITUIDOS NHIBIDORES DE GSK3BETA Y SU EMPLEO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS. | |
AR067927A1 (es) | Quinolinas sustituidas, composiciones y combinaciones que las comprenden y el uso de las mismas en la preparacion de un medicamento para tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio. | |
BR0311347A (pt) | Alcanóis bis-aromáticos | |
AR016422A1 (es) | Compuestos de esteres ciclicos de piperidinilaminometil trifluorometilo como antagonista de la sustancia p; composiciones farmaceuticas y procedimientos detratamiento. | |
AR038029A1 (es) | Derivados de benzotiazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
ECSP066564A (es) | Formulaciones de tableta de liberación extendida de venlafaxina | |
CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
PA8589801A1 (es) | Aminoalcoxiindoles | |
UY26501A1 (es) | Derivados de piperazina sustituidos, su preparación y su empleo como medicamentos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |